IDO1 INVOLVEMENT IN MEDULLOBLASTOMA: A POSSIBLE INTERACTION WITH mTOR

被引：0
|
作者：
Folgiero, Valentina [1 ]
del Bufalo, Francesca [1 ]
Carai, Andrea [1 ]
Cefalo, Maria Giuseppina [1 ]
Citti, Arianna [1 ]
Rutella, Sergio [1 ]
Locatelli, Franco [1 ]
Mastronuzzi, Angela [1 ]
机构：
[1] Bambino Gesu Pediat Hosp, Rome, Italy
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TB-023
引用
收藏
页码：141 / 141
页数：1
相关论文
共 50 条
  • [21] Superiority of dual IDO1/TDO2 inhibition versus IDO1 selective inhibition in reducing immunosuppressive KYN levels in tumors co-expressing IDO1 and TDO2
    Lotz-Jenne, Carina
    Cren, Sylvaine
    Joesch, Christoph
    Ackerknecht, Sabine
    Brandes, Jennifer
    Moebs, Claire
    Hartl, Dominik
    Hartrampf, Felix
    Guerry, Philippe
    Pothier, Julien
    Chavanton-Arpel, Alexia
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (12)
  • [22] Impact of IDO1 and IDO2 on the B Cell Immune Response
    Merlo, Lauren M. F.
    Peng, Weidan
    Mandik-Nayak, Laura
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [23] Amyloid β neurotoxicity is IDO1-Kyn-AhR dependent and blocked by IDO1 inhibitor
    Duan, Zhenzhen
    Zhang, Shengnan
    Liang, Heng
    Xing, Zikang
    Guo, Leilei
    Shi, Lei
    Du, Lisha
    Kuang, Chunxiang
    Takikawa, Osamu
    Yang, Qing
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [24] GS-4361: A novel IDO1 Inhibitor
    Kalla, Rao
    Elbel, Kristy
    Bartlett, Mark
    Cosman, Jennifer
    Perry, Thao
    Elzein, Elfatih
    Li, Xiaofen
    Koltun, Dmitry
    Parkhill, Eric
    Zablocki, Jeff
    Clark, Mike
    Maecker, Heather
    Jawahar, Sudhamsu
    Hendricks, Deborah
    Shornikov, Alex
    Koditek, David
    Stafford, Brian
    Soohoo, Daniel
    Voigt, Johannes
    Lansdon, Eric
    Mackman, Richard
    Corkey, Britton
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [25] IDO1 as a potential diagnostic biomarker for gastric cancer
    Wang, Yulu
    Jin, Yun
    Wang, Tongyu
    Zhou, Ning
    ASIAN JOURNAL OF SURGERY, 2024, 47 (10) : 4351 - 4353
  • [26] IDO1: An important immunotherapy target in cancer treatment
    Li, Fangxuan
    Zhang, Rupeng
    Li, Shixia
    Liu, Juntian
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 47 : 70 - 77
  • [27] ROCHE AND CURADEV SIGN IDO1/TDO PACT
    不详
    CHEMICAL & ENGINEERING NEWS, 2015, 93 (17) : 15 - 15
  • [28] Issues with the Specificity of Immunological Reagents for Murine IDO1
    Van de Velde, Lee-Ann
    Gingras, Sebastien
    Pelletier, Stephane
    Murray, Peter J.
    CELL METABOLISM, 2016, 23 (03) : 389 - 390
  • [29] TARGETING IDO1 IN HUMAN PEDIATRIC BRAIN CANCER
    Lauing, Kristen
    Lulla, Rishi
    Lenzen, Alicia
    Zhai, Lijie
    Hashizume, Rintaro
    Fangusaro, Jason R.
    Wainwright, Derek
    NEURO-ONCOLOGY, 2017, 19 : 120 - 120
  • [30] Innovative drugs targeting IDO1 functions in neoplasia
    Grohmann, U.
    Macchiarulo, A.
    ANNALS OF ONCOLOGY, 2018, 29 : 1 - 1
12345